baber/WOPTO huggingface dataset:
Patent PT-1243258-E (PT)
Inventor: SCHNABELRAUCH MATTHIAS
IPC: A61K9/22
Filed: 2002-03-06
Abstract: The present invention concerns the manufacture and use of an antibiotic/antibiotics preparation for human and veterinary medicine, for the treatment of local microbial infections in hard and soft tissue. The manufacture in accordance with the invention of an antibiotic/antibiotics preparation takes place according to the invention in that water, an amphiphilic component of a representative of the alkyl sulfates, aryl sulfates, alkylaryl sulfates, cycloalkyl sulfates, alkylcycloalkyl sulfates, alkyl sulfamates, cycloalkyl sulfamates, alkylcycloalkyl sulfamates, aryl sulfamates, alkylaryl sulfamates, alkyl sulfonates, fatty acid-2-sulfonates, aryl sulfonates, alkylaryl sulfonates, cycloalkyl sulfonates, cycloalkyl sulfonates, alkylcycloalkyl sulfonates, alkyl disulfates, cycloalkyl disulfates, alkyl disulfonates, cycloalkyl disulfonates, aryl disulfonates, alkylaryl disulfonates, aryl trisulfonates and alkylaryl trisulfonates, one or more antibiotic components from the group of aminoglycoside antibiotics, lincosamide antibiotics and tetracycline antibiotics, an organic auxiliary component and/or an inorganic auxiliary component and if need be at least one biologically active component are mixed together and shaped into molded elements, granulates, powders, foils, shaped masses and threads.
Patent PT-1420789-E (PT)
Title: Use of active ingredients having a ¿-opioid receptor agonist action and an opioid receptor antagonist action, as combination drugs for the treatment of cancer
Inventor: GEISSLINGER GERD
IPC: A61K31/135
Filed: 2002-07-23
Abstract: The invention relates to the use of active ingredients having a mu-opioid receptor agonist action and an opioid receptor antagonist action, as combination drugs for the treatment of cancer.
Patent PT-1498498-E (PT)
Title: Whey powders of improved taste
Inventor: BALZER HARTMUT DR
IPC: C13K5/00
Filed: 2003-07-15
Abstract: The invention refers to whey powder and whey permeate powder containing at least 60% by weight of  beta -lactose, to a process for producing such powder by  (i) adjusting the pH of whey and whey permeate respectively to a value of about 5.5 to 9.5, (ii) optionally partially demineralizing the product obtained in step (i), and (iii) drying the product of step (ii) before crystallization takes place,  to the use of such powder in food applications and to products especially confectionery and chocolate made by the use of such powder.
Patent PT-1689233-E (PT)
Title: Bicyclic inhibitors of mek
Inventor: WALLACE ELI
IPC: C07D413/14
Filed: 2004-11-18
Abstract: Disclosed are compounds of the Formula I   
and pharmaceutically acceptable salts and prodrugs thereof, wherein R 1 , R 2 , R 7 , R 8  and R 9 , W, X and Y are as defined in the specification. Such compounds are MEK inhibitors and useful in the treatment of hyperproliferative diseases, such as cancer and inflammation, in mammals, and inflammatory conditions. Also disclosed are methods of using such compounds in the treatment of hyperproliferative diseases in mammals and pharmaceutical compositions containing such compounds.
Patent PT-1751283-E (PT)
Title: Fed-batch fermentation process and culture medium for the production of plasmid dna in e.coli on a manufacturing scale
Inventor: HUBER HANS
IPC: C12N15/10
Filed: 2005-04-06
Abstract: A process for producing plasmid DNA E. coli cells comprises a pre-culture and fed-batch process. The culture media of the batch phase and the culture medium added during the feeding phase are chemically defined. The culture medium of the feeding phase contains a growth-limiting substrate and is added at a feeding rate that follows a pre-defined exponential function, thereby controlling the specific growth rate at a pre-defined value. The process results in high yield and homogeneity of plasmid DNA.
Patent PT-1851991-E (PT)
Title: Loudspeaker cabinet and reproduction system
Inventor: KALKMAN HUBERT
IPC: H04R1/02
Filed: 2005-10-20
Abstract: A loudspeaker box comprising a first and a second speaker unit each adjacent a sound space formed in the housing. The loudspeaker box further comprises a separation element provided between the sound spaces. The separation element comprises faces to reflect at least a part of sound waves to be radiated by a backside of the speaker units into the sound spaces. As well, the separation element leaves open a passage between the sound spaces. By reflection of sound waves at the faces of the separation element an acoustic influence on the speaker units occurs as a result of which for example an electric filtering of signals being supplied to the speaker units can be dispensed with. In a further aspect of the invention, the loudspeaker box comprises a further compartment that is at least partially filled with a granular material. In this way an effective damping of resonances occurring in the loudspeaker box is reached.
Patent PT-1852173-E (PT)
Title: Process and apparatus for treatment of pollutant containing waste gases
Inventor: RAMHARTER PETER MICHAEL
IPC: B01D53/84
Filed: 2006-05-04
Abstract: The treatment of contaminated waste gases from the thermal utilization of biogenic residual substances, comprises introducing the waste gases under heat supply in an aeration basin/column that contains a reaction medium containing bacteria, transferring the waste gases in the reaction medium, removing the dirt through the reaction medium by heat, residual oxygen and the bacteria, separating the waste gases into purified and unpurified part, binding the unpurified part at the reaction medium for removing formed residual pollutant, and removing purified part from the reaction medium. The treatment of contaminated waste gases from the thermal utilization of biogenic residual substances, comprises introducing the waste gases under heat supply in an aeration basin/column that contains a reaction medium containing bacteria, transferring the waste gases in the reaction medium, removing the dirt through the reaction medium by heat contained in the waste gases, by residual oxygen and by the bacteria, separating the waste gases into a purified and unpurified part, binding the unpurified part at the reaction medium for removing formed residual pollutant, and removing purified part from the reaction medium over its surface. The introduced pollutants in the reaction media are transferred by bacterial processes to form sludge. The reaction medium is sludge, sludge with gas or a mixture of sludge and water. The column is supplied with sludge from a digestion tank, sludge basin or aeration tank, and the sludge is led back after the carrying out the reaction. The hot waste gases are cooled before introducing in the reaction medium. The waste gases are supplied together with condensate produced during the cooling to the reaction medium. The heat emitted during the cooling of the waste gases is supplied to the reaction medium and/or to an external use. The temperature of the reaction medium and the waste gases are 8-14 [deg]C and 1400-25 [deg]C respectively. After separation of the pollutant, the residual pollutant consists of dust particles bound at the reaction medium. The waste gases are led over heat exchangers cooled from the reaction medium. The waste gases with corrosive part are cooled off maximally to the condensation point of the corrosive part outside of the reaction medium. An independent claim is included for a device for the treatment of contaminated waste gases from the thermal utilization of biogenic residual substances.
Patent PT-1731035-E (PT)
Title: Pesticides based on vicinal diols
Inventor: CARVER ANDREW
IPC: A01P7/04
Filed: 2002-02-28
Abstract: Pesticides based on vicinal diols are available to control arthropod ectoparasites such as  Pediculus humanus, Dermatophagoides pteronyssinus, Musca domestica, the Blattidae, Blatella Germanica,  and  Periplaneta Americana,  by introducing to the locus of the infestation of the pest, a composition containing as active ingredient a vicinal diol.
Patent PT-1683675-E (PT)
Title: Cruise management method and device for a road vehicle
Inventor: LUPO SAVINO LUIGI
IPC: B60K31/02
Filed: 2006-01-17
Abstract: A cruise management method and device for a road vehicle (1), wherein the position of an accelerator control (11) is detected, a current speed (CS) of the vehicle (1) is detected and a current transmission ratio is detected; a desired speed (DS) is calculated as a function of the position of the accelerator control (11), the current speed (CS) of the vehicle (1) and the current transmission ratio and is used to control the drive torque generated by an engine (3) of the vehicle (1) and is displayed by a specific display instrument (16) disposed in a dashboard (13) of the vehicle (1).
Patent PT-1867259-E (PT)
Title: Beverage machine with warming support plate
Inventor: GAVILLET GILLES
IPC: A47J31/54
Filed: 2006-06-15
Abstract: The machine has a cup warmer device including a heating body (7) e.g. boiler, that is arranged for transmitting the heat to a cup holder (4) by conduction. The body is connected to a pump (8) i.e. piston pump, for a fluid transportation in the machine. A heat regulating and hydraulic dampening unit (9) is arranged in contact with the heating body for regulating the transfer of heat from the body to the holder and reducing vibrations emitted by the pump to the body, where the regulating and dampening unit is made of elastic and viscoelastic material, elastormeric material and silicone. An independent claim is also included for a method of heating a cup warmer device of a hot drink preparing machine.
Patent PT-1881967-E (PT)
Title: Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics
Inventor: MERLA BEATRIX
IPC: A61K31/423
Filed: 2006-05-18
Abstract: The present invention relates to substituted benzo[d]isoxazol-3-yl-amine compounds, methods for their production, medicaments containing these compounds and the use of these compounds to produce medicaments.
Patent PT-1909938-E (PT)
Title: Method for affinity chromatography of antithrombin iii
Inventor: MOURIER PIERRE
IPC: B01D15/38
Filed: 2006-07-26
Abstract: The present invention is directed to an affinity chromatography column comprising the antithrombin III (ATIII) protein bound to a solid support, characterized in that: a. the ATIII protein is the wild-type protein or a variant thereof, b. the ATIII protein has been first activated by incubation with an unmodified low-molecular-weight heparin (LMWH) rich in active species, and c. the ATIII protein is covalently bound to a resin in a ratio of less than approximately 2 mg of protein per ml of hydrated resin. The invention is also directed to the use of the aforesaid column for purifying species having an affinity for ATIII in a sample comprising species having affinity and not having affinity for ATIII.
Patent PT-1987200-E (PT)
Title: Sealing plate for railway rail clip anchoring device and sleeper manufacturing method
Inventor: COX STEPHEN JOHN
IPC: E01B3/28
Filed: 2007-02-21
Abstract: A sealing plate for use with a rail clip anchoring device having a head and a stem which extends from the head into a concrete sleeper when the anchoring device is in use, is adapted for extending over the underside of the head when the stem of the device is being set in a concrete sleeper, thereby to prevent ingress of concrete into the head of the device, and for being retained on the surface of the sleeper thereafter. A major face of the plate, which is uppermost when the sleeper is in use, is provided with at least one clip seat portion for receiving part of a rail clip. In a method of manufacturing a concrete sleeper with at least one embedded rail clip anchoring device, the floor of a mold, from which the sleeper is to be formed, is provided with an aperture through which the head of an anchoring device is inserted and before concrete is introduced into the mold the aperture is sealed off around its edges and around the underside of the head of the anchoring device by placing a sealing plate over the aperture on the floor of the mold, the plate overlapping and sealing around the edges of the aperture other than where the anchoring device is located and having a mating interface with the anchoring device such that a seal is formed therewith.
Patent PT-574174-E (PT)
Inventor: PFEIFER WILLIAM
IPC: C07D403/10
Filed: 1993-06-02
Abstract: This invention provides pharmaceutical heterocyclic derivatives of the formula <CHEM>  in which R3 are specified nitrogen-containing fused rings. They antagonize angiotensin II receptors in mammals.
Patent PT-629692-E (PT)
Inventor: HAHN WILFRIED
IPC: C11D3/386
Filed: 1994-06-08
Abstract: Liquid enzyme preparations which contain the enzyme as aqueous enzyme particle suspension, highly disperse fillers and a liquid alkylene oxide polymer based on ethylenediamine with a molecular weight in the range from 500 to 8200 are described. The liquid enzyme preparations may contain all enzymes customary for detergents and cleaning purposes, in particular alkaline proteases. Furthermore, a process for the production of these liquid enzyme preparations and the use thereof in liquid detergents and cleaners are described.
Patent PT-828721-E (PT)
Inventor: VILLAMIL CLARA I
IPC: C07D417/12
Filed: 1996-05-23
Abstract: A class of compounds for the treatment of viral infections. Compounds of particular interest are defined by Formula I wherein R-R<4 >are as defined herein, or a pharmaceutically-acceptable salt thereof.
Patent PT-816522-E (PT)
Inventor: MARGARIA THOMAS
IPC: C22C35/00
Filed: 1997-06-23
Abstract: An alloy which is added to the melt when making spheroidal graphite cast iron comprises (wt.%) 0.005-3% rare earths, 0.005-3% bismuth, lead and/or antimony, 0.3-3%, preferably 0.5-2%, calcium, 0.3-3%, preferably 0.5-1.5%, magnesium and the balance silicon and iron in a ratio of Si to Fe of >2, preferably >2.5. The alloy may be added to the melt in the form of wire wool.
Patent PT-806649-E (PT)
Inventor: SILENIUS PETRI
IPC: D21B1/00
Filed: 1997-04-22
Abstract: The invention relates to a procedure for determining a quantity dependent on the rate of diffusion in the fibre wall for diffusion occurring through it, in which procedure a diffusible tracer is introduced into the fibres under measurement, the fibres are suspended in an aqueous phase and the tracer concentration is determined after a certain time has elapsed since the time of suspension of the fibres, and the quantity dependent on the rate of diffusion is calculated on the basis of the concentration and time. <??>In addition, the invention relates to a procedure for determining the proportion of secondary fibre in a fibre suspension containing primary fibre and secondary fibre, in which procedure virtual diffusion coefficients are determined in the fibre wall for diffusion taking place through it in at least two fibre suspensions for which the proportions of primary and secondary fibre are known and in a fibre suspension under measurement, and that the proportion of secondary fibre in the suspension under measurement is estimated by assuming that the diffusion coefficient depends mainly linearly on the proportion of primary and secondary fibre in the fibre suspension. <IMAGE>
Patent PT-904299-E (PT)
Inventor: PETITOU MAURICE
IPC: A61P7/00
Filed: 1997-06-11
Abstract: Synthetic polysaccharides are disclosed containing 8-24 monosaccharide units made up of a concatenation of disaccharides consisting of a uronic acid and a hexose, wherein the hydroxyl groups of the polysaccharides are etherified with a C1-6 alkyl group or esterified in the form of a sulpho group, each disaccharide being at least monoetherified; and salts thereof, are disclosed.
Patent PT-921725-E (PT)
Inventor: PEDERSEN MORTEN
IPC: A01N57/14
Filed: 1997-08-19
Abstract: Addition of oxidation agent to completely or partially water-based organophosphate pesticide formulations or solid organophosphate pesticide formulations improves the chemical stability of the pesticide, minimizes formation of toxic isomeric compounds and eliminates the development of mercaptan and sulphide smell.
Patent PT-887412-E (PT)
Inventor: MUNDT E
IPC: A61K39/12
Filed: 1998-05-22
Abstract: The present invention provides a birnavirus mutant which is suited as vaccine candidate in eradication control programmes. The mutant is not able to produce a native VP5 protein, and this feature can be used as a marker to distinguish between animals vaccinated with the VP5 mutant or infected with a naturally-occurring birnavirus.
Patent PT-973724-E (PT)
Inventor: NICOLAS MARC
IPC: C07C229/36
Filed: 1998-04-06
Abstract: PCT No. PCT/EP98/02213 Sec. 371 Date Dec. 20, 1999 Sec. 102(e) Date Dec. 20, 1999 PCT Filed Apr. 6, 1998 PCT Pub. No. WO98/45248 PCT Pub. Date Oct. 15, 1998Process for the preparation of cericlamine which consists: i) in arylating methacrylic acid with the diazonium chloride of 3,4-dichloroaniline, to obtain (+/-)2-chloro-3-(3,4-dichlorophenyl)-2-methylpropionic acid, ii) in aminating the acid with dimethylamine, to obtain (+/-)3-(3,4-dichlorophenyl)-2-dimethylamino-2-methylpropionic acid, or an alkaline metal salt thereof, iii) in esterifying the amino-acid or its salt, then, iv) in reducing the ester by a metal or organometal hydride to obtain (+/-)3-(3,4-dichlorophenyl)-2-dimethylamino-2-methyl-propan-1-ol.
Patent PT-942023-E (PT)
Inventor: PETZOLDT JOACHIM
IPC: C08G18/80
Filed: 1999-03-01
Abstract: Aqueous or water-dilutable blocked polyisocyanate (I) consists of:   (a) 100 equivalent-% polyisocyanate component, (b) 60-85 equivalent-% pyrazole compound as blocking agent, (c) 15-40 equivalent-% monohydroxycarboxylic acid to give hydrophilic properties and (d) 0-15 equivalent-% difunctional chain extender with hydroxyl (OH) and/or amino groups. The ratio of isocyanate (NCO) groups in (a) to NCO-reactive groups in (b), (c) and (d) is 1:(0.8-1.2). An Independent claim is also included for the preparation of (I).
Patent PT-1087334-E (PT)
Title: Multi-use electronic seal with passive transponder
Inventor: KORN CHRISTOPHE
IPC: B65G1/137
Filed: 1999-09-15
Abstract: The invention concerns a system to be sealed, comprising a first capsule (20), a second capsule (30), electronic means (23, 33) designed to be arranged in at least one of the caps, containing an electronic identification capable of being remotely interrogated, closing means (25-1, 25-2, 25-3, 25-4; 35-1, 35-2, 35-3, 35-4), for sealing the two capsules together.
Patent SG-36085-G (SG)
Title: After treatment of cellulosic fibres dyed with reactive dyes
IPC: D06P3/66
Filed: 1985-05-14
Abstract: A process for dyeing or printing with a fibre-reactive dyestuff a substrate consisting of or comprising cellulosic fibres, which process comprises treating the dyed or printed substrate, at a temperature from 20 DEG  to 105 DEG  C. with an aqueous solution of a polymer containing carboxylic acid groups at least partially neutralized in salt form.
Patent SG-80584-G (SG)
Title: Self-contained gas powered surgical stapler
IPC: B25C5/02
Filed: 1984-11-12
Abstract: A surgical stapler powered by a relatively low pressure gas supply contained in the stapler. The stapler has a mechanical linkage between the pneumatic actuator and the staple driver with a differential mechanical advantage to match the substantially constant force provided by the pneumatic actuator to the different forces required to first advance and then form the staple. This mechanical linkage allows use of a relatively small low pressure actuator and also substantially increases the efficiency with which the gas supply is utilized.
Patent IE-850309-L (IE)
Title: Infusion system
IPC: A61M5/172
Filed: 1985-02-08
Abstract: An infusion system (10) comprises means (12, 16, 18, 20, 34, 46, 52) for infusing at least one fluid to be infused into the circulatory system of the patient along a fluid flow path (24); means (40) coupled to the fluid flow path (24) for providing data representative of pressure along the fluid flow path, and means (48) coupled to the pressure data providing means (40) and to the infusing means and responsive to the pressure data. For enhancing the accuracy of the rate of flow, said means (48) responsive on the pressure data adapt the rate of flow as a function of said pressure data to maintain a desired flow rate.
[EP0288717A1]
Patent IE-43843-L (IE)
Title: Forming blocks of cheese
IPC: A01J25/12
Filed: 1976-04-02
Abstract: Crumbled cheese curd is fed into the top of a hollow column in a chamber maintained at a sub-atmospheric pressure so as to form in the column a pillar of curd devoid of air pockets. The curd in the lower portion of the pillar being compressed by the weight of superimposed curd to press out whey therefrom and consolidate the curd, and the pillar of curd is repeatedly lowered, the bottom end of the pillar severed to form a block of cheese, and fresh curd added to the top of the pillar. During the lowering of the pillar of curd, the top of the pillar is subjected to a higher pressure than that acting on the bottom of the pillar so that the differential pressure exerts a force on the top of the pillar urging the pillar downwards and prevents fracture of the pillar due to frictional resistance with the walls of the column. The curd is fed into the chamber through a feedpipe connected between the top of the chamber and the outlet of a hopper containing curd under atmospheric pressure, the differential pressure between the hopper and the chamber causing curd to flow along the feedpipe. The feedpipe discharges into a cyclone separator in the top of the chamber for separating air from the curd.
[US4061794A]
Patent IE-850732-L (IE)
Title: Immunosuppressant factor
IPC: C07K14/005
Filed: 1985-03-22
Abstract: An immunosuppressant factor and factor which exhibits interleukin-1-like activity, derived from human glioblastoma cells.
Patent IE-780760-L (IE)
Title: Cephalosporin antibiotics
IPC: C07D501/60
Filed: 1978-04-18
Abstract: Cephalosporin derivatives of the formula: <IMAGE> in which R<1> denotes lower alkyl and R<2> denotes hydrogen or lower alkyl. In contrast to the free carboxylic acids, these novel esters are very well absorbed by the gastrointestinal tract and then hydrolyse rapidly to give corresponding carboxylic acids having a broad spectrum antibiotic action. They are prepared by esterification of the carboxyl group in the 4-position, by N-acylation of the 7-aminocephemcarboxylic acid ester or by carbamoylation of the hydroxymethyl group in the 3-position.
[GB1598568A]
Patent FI-814032-L (FI)
Inventor: ZEUGNER HORST
IPC: C07D491/02
Filed: 1981-12-16
Abstract: Novel 2-acyl amino methyl-5-phenyl-1H-2,3-dihydro-1,4-benzo diazepine compounds of the following Formula I    <IMAGE>  I  which have valuable pharmacological properties are provided. In said Formula I the acyl group -CO-R3 represents a benzoyl group or a phenyl alkanoyl group which may be unsubstituted or mono- or di-substituted in the phenyl ring. The substituent R1 in said compounds indicates lower alkyl, lower alkenyl, or cyclopropyl methyl, and the substituent R2 indicates hydrogen, lower alkyl, or lower alkenyl, while the substituent R6 indicates hydrogen, halogen, lower alkyl, lower alkoxy, hydroxyl, lower alkylthio, nitro, trifluoro methyl, cyano, amino, mono- or di-lower alkyl amino, lower mono-alkanoyl amino, lower N-alkyl-N-alkanoyl amino, or lower alkanoyloxy, and the substituent R7 indicates hydrogen, halogen, lower alkyl, lower alkoxy, hydroxyl, or lower alkanoyloxy, whereby R6 and R7, when attached to adjacent carbon atoms, may form together the methylene dioxy or the ethylene dioxy group. The substituents R8 and R9 designate the same substituents as indicated for the substituents R6 and R7. The compounds of Formula I have a surprising analgesic activity.